tiprankstipranks
Advertisement
Advertisement

SRRK Stock Latest News

Scholar Rock price target raised to $57 from $54 at Jefferies
The FlyScholar Rock price target raised to $57 from $54 at Jefferies
10d ago
SRRK
De-Risked Regulatory Path and Manufacturing Readiness Underpin Buy Rating on Apitegromab
PremiumRatings
De-Risked Regulatory Path and Manufacturing Readiness Underpin Buy Rating on Apitegromab
11d ago
SRRK
Morning News Wrap-Up 3/31/26: Today’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up 3/31/26: Today’s Biggest Stock Market Stories!
11d ago
UL
AMD
Scholar Rock price target raised to $58 from $51 at BofA
PremiumThe Fly
Scholar Rock price target raised to $58 from $51 at BofA
11d ago
SRRK
Apitegromab: Strengthened Regulatory Position and Dual-Site Strategy De-Risk Approval and Commercialization
PremiumRatings
Apitegromab: Strengthened Regulatory Position and Dual-Site Strategy De-Risk Approval and Commercialization
11d ago
SRRK
Scholar Rock resubmission ‘material de-risking event,’ says H.C. Wainwright
PremiumThe FlyScholar Rock resubmission ‘material de-risking event,’ says H.C. Wainwright
11d ago
SRRK
Scholar Rock price target raised to $60 from $53 at Raymond James
Premium
The Fly
Scholar Rock price target raised to $60 from $53 at Raymond James
11d ago
SRRK
Scholar Rock Resubmits Apitegromab BLA, Expands Manufacturing Plans
Premium
Company Announcements
Scholar Rock Resubmits Apitegromab BLA, Expands Manufacturing Plans
11d ago
8K
SRRK
Scholar Rock rises 15.5%
PremiumThe Fly
Scholar Rock rises 15.5%
11d ago
SRRK
What Sent Scholar Rock Holding Stock (SRRK) Higher Today?
PremiumMarket News
What Sent Scholar Rock Holding Stock (SRRK) Higher Today?
11d ago
NVO
SRRK
Scholar Rock up 12% at $48.27 after resubmitting BLA to FDA for apitegromab
PremiumThe Fly
Scholar Rock up 12% at $48.27 after resubmitting BLA to FDA for apitegromab
12d ago
SRRK
Scholar Rock resubmits BLA to FDA for apitegromab
PremiumThe Fly
Scholar Rock resubmits BLA to FDA for apitegromab
12d ago
SRRK
Scholar Rock extends rally after Cantor note, shares up 14% to $45.34
PremiumThe FlyScholar Rock extends rally after Cantor note, shares up 14% to $45.34
23d ago
SRRK
Cantor sees Scholar Rock dominating SMA market after Genentech news
Premium
The Fly
Cantor sees Scholar Rock dominating SMA market after Genentech news
23d ago
CHRO
SRRK
Cantor sees Scholar Rock dominating SMA market after Genentech drops out
Premium
The Fly
Cantor sees Scholar Rock dominating SMA market after Genentech drops out
23d ago
CHRO
SRRK
Scholar Rock jumps 8% after Cantor says Genentech stopped SMA drug
PremiumThe Fly
Scholar Rock jumps 8% after Cantor says Genentech stopped SMA drug
23d ago
SRRK
Scholar Rock price target raised to $50 from $47 at JPMorgan
PremiumThe Fly
Scholar Rock price target raised to $50 from $47 at JPMorgan
27d ago
SRRK
Scholar Rock Eyes 2026 Launch Amid Regulatory Push
PremiumCompany Announcements
Scholar Rock Eyes 2026 Launch Amid Regulatory Push
1M ago
SRRK
Scholar Rock price target raised to $55 from $44 at Truist
PremiumThe Fly
Scholar Rock price target raised to $55 from $44 at Truist
1M ago
SRRK
Scholar Rock price target raised to $58 from $51 at Piper Sandler
PremiumThe FlyScholar Rock price target raised to $58 from $51 at Piper Sandler
1M ago
SRRK
Scholar Rock: Positive Regulatory Trajectory and Commercial Readiness for Apitegromab Support Buy Rating and Multi‑Billion‑Dollar SMA Potential
Premium
Ratings
Scholar Rock: Positive Regulatory Trajectory and Commercial Readiness for Apitegromab Support Buy Rating and Multi‑Billion‑Dollar SMA Potential
1M ago
SRRK
Scholar Rock price target raised to $70 from $50 at BMO Capital
Premium
The Fly
Scholar Rock price target raised to $70 from $50 at BMO Capital
1M ago
SRRK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >